International Journal of Risk & Safety in Medicine - Volume 1, issue 3
Purchase individual online access for 1 year to this journal.
Price: EUR 155.00
The International Journal of Risk and Safety in Medicine is concerned with rendering the practice of medicine as safe as it can be; that involves promoting the highest possible quality of care, but also examining how those risks which are inevitable can be contained and managed.
This is not exclusively a drugs journal. Recently it was decided to include in the subtitle of the journal three items to better indicate the scope of the journal, i.e. patient safety, pharmacovigilance and liability and the Editorial Board was adjusted accordingly. For each of these sections an Associate Editor was invited. We especially want to emphasize patient safety. Our journal wants to publish high quality interdisciplinary papers related to patient safety, not the ones for domain specialists. For quite some time we have also been devoting some pages in every issue to what we simply call WHO news. This affinity with WHO underlines both the International character of the journal and the subject matter we want to cover. Basic research, reports of clinical experience and overviews will all be considered for publication, but since major reviews of the literature are often written at the invitation of the Editorial Board it is generally advisable to consult with the Editor in advance. Submission of news items will be appreciated, as will be the contribution of letters on topics which have been dealt with in the journal.
Abstract: The spectrum of teratogenic and carcinogenic effects which can be exerted when the unborn child is exposed to diethylstilbestrol (DES) has been shown to be broad. Animal work indicates the need for vigilance as regards genetic susceptibility to DES sequelae. The emergence of third generation sequelae has been demonstrated in mice, and has been postulated to occur in humans. Given the emergent data establishing problems of infertility in men and women and of relatively late onset cancer, and the possibility that in utero exposure to DES may prime a variety of tissues to noxious environmental influences there is an urgent…need for measures to provide just coverage for those harmed by the drug. The DES disaster also raises important ethical and reserch questions which demand attention.
Abstract: There is a major gap in knowledge as regards the epidemiology and nature of medical accidents. Major studies, such as the Harvard Medical Practice Study, are required in the UK and elsewhere to identify common accidents and assess the needs of the patients involved. Such work would also provide an estimate of the likely cost of a no-fault compensation scheme. The study of critical incidents and “near misses” should form a regular part of clinical audit, as should the study of communications among medical staff and between care staff and patients. Existing work points to the need to review the…training needs of junior doctors, especially in relation to the provision of consultant supervision, and to the need for counselling of all the parties, doctor and patient alike, who are involved in medical accidents.
Keywords: Medical accidents, Research, Obstetrics, Anesthesia